Mebeverin Puren (Mebeverine Hydrochloride)

Mebeverine hydrochloride relaxes gastrointestinal smooth muscle by inhibiting calcium entry into the cells and modulating muscarinic receptors, which reduces muscle spasms without impairing normal intestinal movement.

The dosage of Mebeverin Puren is determined by the prescribing clinician based on the individual’s condition, severity of symptoms, and overall health status. Patients should follow the prescriber’s instructions.

Safety data for mebeverine hydrochloride in pregnancy and lactation are limited. Use only if the potential benefit justifies the potential risk and after consultation with a healthcare professional.

Enquiries can be submitted on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Mebeverin Puren (mebeverine) is a direct smooth‑muscle relaxant that does not possess anticholinergic activity, unlike some alternatives such as hyoscine. This profile may result in fewer anticholinergic side effects such as dry mouth or blurred vision.

Store Mebeverin Puren at ambient temperature, below 25 °C, in the original packaging and protect it from moisture and direct sunlight to maintain product stability.

Mebeverin Puren is taken orally, usually with or without food, as directed by the prescribing physician. Swallow the tablet whole with a glass of water.

Serious but rare risks include severe allergic reactions such as rash, angioedema, Stevens‑Johnson syndrome, and rare cardiac arrhythmias. Patients should seek immediate medical attention if they experience any signs of a serious reaction.

Individuals with known hypersensitivity to mebeverine hydrochloride or any excipients in the formulation should avoid using Mebeverin Puren. Caution is also advised for patients with severe renal impairment until evaluated by a physician.